NCI Renewal Grant To Develop New Cancer Therapies

December 05th, 2007 | Category: Cancer

A Virginia Commonwealth University Massey Cancer Center research team has received a renewal grant totaling nearly $1.3 million from the National Cancer Institute to improve the activity of a novel class of agents, known as histone

deacetylase inhibitors, in the treatment of leukemia and other blood malignancies.Through the five-year grant, Steven Grant, M.D. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Grant From NIH To Advance Brain Tumor Therapies From Lab To Clinical Trials
  • Second-moment Designation From National Cancer Institute Received By MCG
  • $11.5 Million Renewal Grant For Breast Cancer Specialized Program Of Research Excellence
  • Personalized Therapy For Brain Tumors Advanced By Major Grant
  • $3.8 Million Research Grant Won By Musculoskeletal Center

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.